Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Global X FTSE Southeast Asia ETF (ASEA) Price & Performance

Amylx Pharmaceuticals IncTrade
Global X FTSE Southeast Asia ETFTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Global X FTSE Southeast Asia ETF — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Global X FTSE Southeast Asia ETF trades at $21.47. Which is the better fit depends on your goals.

AMLXASEA
Market Cap
$2.64B
Sector
HealthSector/Thematic
52-Week High
$24.19$21.53
52-Week Low
$7.82$16.86
Enterprise Value
$2.39B

Returns comparison

Trailing returns across standard periods

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Global X FTSE Southeast Asia ETF

ASEA tracks the performance of the largest companies in Southeast Asia. It provides exposure to key emerging markets including Singapore, Indonesia, Thailand, and Malaysia, with a heavy focus on financials like DBS Group and Bank Central Asia.

Read more on ASEA